DOUBLE-BLIND COMPARISON OF THE EFFICACY OF CONTINUED ZIDOVUDINE VERSUS 2',3'-DIDEOXYINOSINE (DDI) (BMY-40900) FOR THE TREATMENT OF PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX AND INCREASING SYMPTOMATOLOGY DESPITE TREATMENT WITH ZIDOVUDINE: